Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy

You may also be interested in:

Magazine 2,733

Does concealed chronic kidney disease predict survival of older patients discharged from acute care hospitals?

Authors: Corsonello A, Pedone C, Lattanzio F, Garasto S, Corica F, Bustacchini S, Guffanti EE, Abbatecola AM, Mari V, Fimognari FL, Incalzi RA.

Date: 2010

Scope of interest: ageing, geriatrics

Read details

Report/Poster of Convention/Congress Act

Chronic liver diseases in the prison population

Authors: Dell 'Isola

Date: 2012

Scope of interest: prison health

Read details

Report/Poster of Convention/Congress Act

White matter abnormalities as endophenotypes of schizophrenia in 22q11 deletion syndrome

Authors: M. Frascarelli, N. Petsas, A. Buzzanca, M. Fanella, A.M. Monacelli, T. Accinni, G.M. Lattanzi, L. Carlone, C. Colonnese, P.Pantano, M. biondi, F. Di Fabio

Date: 2019

Scope of interest: Neuroimaging/rare diseases/psychiatric disorders

Read details